You are here: Industry Insights > Diabetes

News List

Biocon Biologics and Voluntis collaborate on digital therapeutics for insulins expresspharma
July 22, 2020
Insulia is the first digital therapeutic with regulatory clearance to provide automated titration recommendations for all types of basal insulins.
Bayer's finerenone hits targets in diabetes/kidney disease trial pharmatimes
July 14, 2020
Bayer's finerenone has hit key targets in a late-stage trial assessing its safety and efficacy in patients with chronic kidney disease (CKD) and type 2 diabetes.
Lupin recalls diabetes treatment drug in US expresspharma
July 13, 2020
The company said that it is voluntarily recalling its Metformin Hydrochloride extended-release tablets USP, 500 mg and 1000 mg products in the US.
Re-purposed drugs could reverse blood vessel damage in diabetes expresspharma
June 30, 2020
In a breakthrough, scientists have discovered a key mechanism that triggers changes in the blood vessels, which can eventually lead to cardiovascular disease.
Cipla and Boehringer Ingelheim to co-market three oral anti-diabetic drugs expresspharma
June 30, 2020
The two companies will help co-market three anti-diabetic drugs Oboravo (Empagliflozin), Oboravo Met (Empagliflozin+Metformin) and Tiptengio (Empagliflozin+Linagliptin).
FDA Approves Lyumjev americanpharmaceuticalreview
June 29, 2020
The U.S. Food and Drug Administration (FDA) has approved Lyumjev™ (insulin lispro-aabc injection, 100 units/mL and 200 units/mL), Eli Lilly and Company's new rapid-acting insulin indicated to improve glycemic control in adults with type 1 and ...
NHS rolls out new online support for diabetes management pharmatimes
June 11, 2020
NHS England has launched new online services to allow people with diabetes to better manage their condition remotely during the coronavirus pandemic.
Marksans Pharma recalls 11,279 bottles of diabetes drug due to cancer causing chemical expresspharma
June 11, 2020
The company has issued voluntary recall of one batch of Metformin extended release tablets (USP 500 mg) due to detection of NDMA.
US FDA asks five firms to recall diabetes drug with high NDMA levels expresspharma
May 29, 2020
It named Apotex Corp as one of the firms whose metformin tablets have high levels of NDMA, but did not reveal the other four firms.
Novo Nordisk launches social responsibility strategy for diabetes pharmatimes
May 28, 2020
Novo Nordisk has launch a new social responsibility strategy Defeat Diabetes.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 37 38 Next page